Stay updated on IMGN779 in CD33+ AML: Clinical Trial

Sign up to get notified when there's something new on the IMGN779 in CD33+ AML: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMGN779 in CD33+ AML: Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.5.3 to v3.5.4. This reflects a minor page version update and does not modify the study content or other user-facing information.
    Difference
    0.1%
    Check dated 2026-05-17T08:57:56.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page’s interface/version revision is updated from v3.5.2 to v3.5.3, indicating a minor release of the site software rather than a change to the study record.
    Difference
    0.1%
    Check dated 2026-04-25T18:40:43.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:34:44.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision log updated: added Revision v3.5.0 and removed Revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-28T01:41:15.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Site revision updated to v3.4.3 and v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-06T18:52:36.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    No additions or deletions are visible; the page content appears unchanged between the two screenshots.
    Difference
    0.1%
    Check dated 2026-02-27T19:01:27.000Z thumbnail image

Stay in the know with updates to IMGN779 in CD33+ AML: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMGN779 in CD33+ AML: Clinical Trial page.